287 related articles for article (PubMed ID: 32459374)
1. Small-Molecule Inhibitors Targeting Sterol 14α-Demethylase (CYP51): Synthesis, Molecular Modelling and Evaluation Against Candida albicans.
Binjubair FA; Parker JE; Warrilow AG; Puri K; Braidley PJ; Tatar E; Kelly SL; Kelly DE; Simons C
ChemMedChem; 2020 Jul; 15(14):1294-1309. PubMed ID: 32459374
[TBL] [Abstract][Full Text] [Related]
2. Sterol 14α-Demethylase Structure-Based Design of VNI (( R)- N-(1-(2,4-Dichlorophenyl)-2-(1 H-imidazol-1-yl)ethyl)-4-(5-phenyl-1,3,4-oxadiazol-2-yl)benzamide)) Derivatives To Target Fungal Infections: Synthesis, Biological Evaluation, and Crystallographic Analysis.
Friggeri L; Hargrove TY; Wawrzak Z; Blobaum AL; Rachakonda G; Lindsley CW; Villalta F; Nes WD; Botta M; Guengerich FP; Lepesheva GI
J Med Chem; 2018 Jul; 61(13):5679-5691. PubMed ID: 29894182
[TBL] [Abstract][Full Text] [Related]
3. The clinical candidate VT-1161 is a highly potent inhibitor of Candida albicans CYP51 but fails to bind the human enzyme.
Warrilow AG; Hull CM; Parker JE; Garvey EP; Hoekstra WJ; Moore WR; Schotzinger RJ; Kelly DE; Kelly SL
Antimicrob Agents Chemother; 2014 Dec; 58(12):7121-7. PubMed ID: 25224009
[TBL] [Abstract][Full Text] [Related]
4. Pyridylethanol(phenylethyl)amines are non-azole, highly selective Candida albicans sterol 14α-demethylase inhibitors.
Ogris I; Zelenko U; Sosič I; Gobec M; Skubic C; Ivanov M; Soković M; Kocjan D; Rozman D; Golič Grdadolnik S
Bioorg Chem; 2021 Jan; 106():104472. PubMed ID: 33261849
[TBL] [Abstract][Full Text] [Related]
5. Structural analyses of
Hargrove TY; Friggeri L; Wawrzak Z; Qi A; Hoekstra WJ; Schotzinger RJ; York JD; Guengerich FP; Lepesheva GI
J Biol Chem; 2017 Apr; 292(16):6728-6743. PubMed ID: 28258218
[TBL] [Abstract][Full Text] [Related]
6. The Evolution of Azole Resistance in
Warrilow AG; Nishimoto AT; Parker JE; Price CL; Flowers SA; Kelly DE; Rogers PD; Kelly SL
Antimicrob Agents Chemother; 2019 May; 63(5):. PubMed ID: 30783005
[TBL] [Abstract][Full Text] [Related]
7. Design and optimization of highly-selective fungal CYP51 inhibitors.
Hoekstra WJ; Garvey EP; Moore WR; Rafferty SW; Yates CM; Schotzinger RJ
Bioorg Med Chem Lett; 2014 Aug; 24(15):3455-8. PubMed ID: 24948565
[TBL] [Abstract][Full Text] [Related]
8. Nitrate Esters of Heteroaromatic Compounds as Candida albicans CYP51 Enzyme Inhibitors.
Smiljkovic M; Matsoukas MT; Kritsi E; Zelenko U; Grdadolnik SG; Calhelha RC; Ferreira ICFR; Sankovic-Babic S; Glamoclija J; Fotopoulou T; Koufaki M; Zoumpoulakis P; Sokovic M
ChemMedChem; 2018 Feb; 13(3):251-258. PubMed ID: 29235267
[TBL] [Abstract][Full Text] [Related]
9. The amino acid substitution N136Y in Candida albicans sterol 14alpha-demethylase is involved in fluconazole resistance.
Alvarez-Rueda N; Fleury A; Logé C; Pagniez F; Robert E; Morio F; Le Pape P
Med Mycol; 2016 Oct; 54(7):764-775. PubMed ID: 27143634
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, in vitro evaluation and molecular docking studies of new triazole derivatives as antifungal agents.
Jiang Y; Zhang J; Cao Y; Chai X; Zou Y; Wu Q; Zhang D; Jiang Y; Sun Q
Bioorg Med Chem Lett; 2011 Aug; 21(15):4471-5. PubMed ID: 21737273
[TBL] [Abstract][Full Text] [Related]
11. Clotrimazole as a potent agent for treating the oomycete fish pathogen Saprolegnia parasitica through inhibition of sterol 14α-demethylase (CYP51).
Warrilow AG; Hull CM; Rolley NJ; Parker JE; Nes WD; Smith SN; Kelly DE; Kelly SL
Appl Environ Microbiol; 2014 Oct; 80(19):6154-66. PubMed ID: 25085484
[TBL] [Abstract][Full Text] [Related]
12. Antifungal screening and in silico mechanistic studies of an in-house azole library.
Sari S; Kart D; Sabuncuoğlu S; Doğan İS; Özdemir Z; Bozbey İ; Gencel M; Eşsiz Ş; Reynisson J; Karakurt A; Saraç S; Dalkara S
Chem Biol Drug Des; 2019 Sep; 94(5):1944-1955. PubMed ID: 31260179
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, and in vitro antifungal activity of 1-[(4-substituted-benzyl)methylamino]-2-(2,4-difluorophenyl)-3-(1H-1,2,4-triazol-1-yl)propan-2-ols.
Guillon R; Pagniez F; Giraud F; Crépin D; Picot C; Le Borgne M; Morio F; Duflos M; Logé C; Le Pape P
ChemMedChem; 2011 May; 6(5):816-25. PubMed ID: 21370476
[TBL] [Abstract][Full Text] [Related]
14. Discovery of new azoles with potent activity against Candida spp. and Candida albicans biofilms through virtual screening.
Sari S; Kart D; Öztürk N; Kaynak FB; Gencel M; Taşkor G; Karakurt A; Saraç S; Eşsiz Ş; Dalkara S
Eur J Med Chem; 2019 Oct; 179():634-648. PubMed ID: 31279296
[TBL] [Abstract][Full Text] [Related]
15. S279 point mutations in Candida albicans Sterol 14-α demethylase (CYP51) reduce in vitro inhibition by fluconazole.
Warrilow AG; Mullins JG; Hull CM; Parker JE; Lamb DC; Kelly DE; Kelly SL
Antimicrob Agents Chemother; 2012 Apr; 56(4):2099-107. PubMed ID: 22252802
[TBL] [Abstract][Full Text] [Related]
16. In silico and in vitro screening to identify structurally diverse non-azole CYP51 inhibitors as potent antifungal agent.
Singh A; Paliwal SK; Sharma M; Mittal A; Sharma S; Sharma JP
J Mol Graph Model; 2016 Jan; 63():1-7. PubMed ID: 26579619
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and antifungal evaluation of 1-(2-(2,4-difluorophenyl)-2-hydroxy-3-(1H-1,2,4-triazol-1-yl)propyl)-1H-1,2,4-triazol-5(4H)-one.
Jiang Y; Cao Y; Zhang J; Zou Y; Chai X; Hu H; Zhao Q; Wu Q; Zhang D; Jiang Y; Sun Q
Eur J Med Chem; 2011 Jul; 46(7):3135-41. PubMed ID: 21354675
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and antifungal activity of some new imidazole and triazole derivatives.
Rezaei Z; Khabnadideh S; Zomorodian K; Pakshir K; Kashi G; Sanagoei N; Gholami S
Arch Pharm (Weinheim); 2011 Oct; 344(10):658-65. PubMed ID: 21984016
[TBL] [Abstract][Full Text] [Related]
19. Molecular Docking Evaluation of Imidazole Analogues as Potent Candida albicans 14α-Demethylase Inhibitors.
Rani N; Kumar P; Singh R; Sharma A
Curr Comput Aided Drug Des; 2015; 11(1):8-20. PubMed ID: 26081558
[TBL] [Abstract][Full Text] [Related]
20. Design and synthesis of novel imidazole-substituted dipeptide amides as potent and selective inhibitors of Candida albicans myristoylCoA:protein N-myristoyltransferase and identification of related tripeptide inhibitors with mechanism-based antifungal activity.
Devadas B; Freeman SK; Zupec ME; Lu HF; Nagarajan SR; Kishore NS; Lodge JK; Kuneman DW; McWherter CA; Vinjamoori DV; Getman DP; Gordon JI; Sikorski JA
J Med Chem; 1997 Aug; 40(16):2609-25. PubMed ID: 9258368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
